NCI to Fund Biomarker Studies Based on Unique Cancer Biorepository | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute intends to fund investigators who will use samples and data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening (PLCO) trial to study the etiology of cancer and develop early detection biomarkers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.